ForexLive European FX news wrap: UK approves Pfizer vaccine; sterling falls on Brexit jitters #money #BrexitTransition #fx #markets #GBPnews https://t.co/fvVR25Wvqm…
Dollar slightly firmer in European morning trade so far #money #currency #fx #markets #USDnews https://t.co/GJd7Ji1MYP — S_FX (@sueyangfx) December 2,…
Dollar Down as Hopes Grow for Rekindled U.S. Stimulus Talks #money #currency #fx #markets #USDnews https://t.co/CTpybhPqfX — S_FX (@sueyangfx) December…
Australian Dollar Forecast: AUD/USD Whipsaws on Upbeat AU GDP Print #money #currency #fx #markets #USDnews https://t.co/nXTTtfrtdF — S_FX (@sueyangfx) December…
EUR/USD breaks the September high in fresh rise above 1.20 #money #currency #fx #markets #EURnews https://t.co/5BPvxUtraQ — S_FX (@sueyangfx) December…
Facebook changes its Libra cryptocurrency's name to Diem #money #currency #fx #markets #USDnews https://t.co/XOua2CqcIC — S_FX (@sueyangfx) December 1, 2020…
USD/JPY Forecast: Yen Remains Robust with Bleak Dollar Outlook #money #currency #fx #markets #USDnews https://t.co/Bfts15rC58 — S_FX (@sueyangfx) December 1,…
Cable eases back to key near-term levels on pullback after testing 1.3400 #money #BrexitTransition #fx #markets #GBPnews https://t.co/a5hnGXa5Fy — S_FX…
Canadian Dollar Aiming Higher on Record GDP Print, Additional Fiscal Aid #money #currency #fx #markets #USDnews https://t.co/izYxzNonAT — S_FX (@sueyangfx)…
Eurostoxx futures +0.4% in early European trading #money #currency #fx #markets #EURnews https://t.co/LvQ0NpRPOE — S_FX (@sueyangfx) December 1, 2020 By…
ForexLive Asia FX news wrap: EUR/USD recovers some of its US timezone loss #money #currency #fx #markets #EURnews https://t.co/wwBYawRYqP —…
Disclaimer & Agreement
Under no circumstances should any information presented on this website, "SYFX", be construed as an offer to sell, or solicitation of any offer to purchase, any securities or other investments. This website does not contain the information that an investor should consider or evaluate to make a potential investment. Offering materials relating to investments in entities managed by SYFX are not available to the general public.
To view this content, you must agree to the following terms, in addition to and supplementing the SYFX Terms of Use and Privacy Policy:
I confirm to SYFX and agree that:
I understand that this website does not contain the information I would need to consider for an investment, and that such information is only available to a limited group of persons and institutions meeting specified criteria.
I understand that this website has not been reviewed or approved by, filed with, or otherwise furnished to any governmental or similar authority, and is intended only to provide limited information to members of the public who have a legitimate interest in that information for reasons unrelated to making investments.
I understand that when SYFX makes third party information available, SYFX generally will not have verified statements made by the third party, and the presentation of information may omit important information.
I understand that third party materials such as live interviews made available by SYFX generally will not have been edited by SYFX and statements in those materials by individuals associated with SYFX should be understood in the conversational context in which they were made, which may include providing historical background.
The content constitutes the proprietary intellectual property of SYFX or its licensors and that I will not directly or indirectly copy, modify, recast, create derivative works, post, publish, display, redistribute, disclose, or make available the content, in whole or in part, to any third parties, or assist others to do the same, or otherwise make any commercial use of the content without the prior written consent of SYFX.
By registering my information below and clicking "Agree," I certify that I have read, understand and agree to the foregoing Disclaimer, Terms of Use and Privacy Policy.